{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:39:06Z","timestamp":1795019946358,"version":"4.10.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"European Research Area Network on Cardiovascular Diseases,Germany","award":["MacroERA"],"award-info":[{"award-number":["MacroERA"]}]},{"name":"European Research Area Network on Cardiovascular Diseases,Germany","award":["01KL1706"],"award-info":[{"award-number":["01KL1706"]}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G091018N"],"award-info":[{"award-number":["G091018N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Cardiovascular Research Initiative","award":["CVON Arena-PRIME, 2017\u201318"],"award-info":[{"award-number":["CVON Arena-PRIME, 2017\u201318"]}]},{"DOI":"10.13039\/501100020407","name":"European Research Area Network on Cardiovascular Diseases","doi-asserted-by":"publisher","award":["LYMIT-Dis"],"award-info":[{"award-number":["LYMIT-Dis"]}],"id":[{"id":"10.13039\/501100020407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Viral myocarditis (VM) is an important cause of heart failure (HF) in children and adults. However, the molecular determinants involved in cardiac inflammation and cardiomyocyte necrosis remain poorly characterized, and cardioprotective molecules are currently missing. Here, we applied an in vivo method based on the functional selection (FunSel) of cardioprotective factors using AAV vectors for the unbiased identification of novel immunomodulatory molecules in a Coxsackievirus B3 (CVB3)-induced myocarditis mouse model. Two consecutive rounds of in vivo FunSel using an expression library of 60 cytokines were sufficient to identify five cardioprotective factors (IL9, IL3, IL4, IL13, IL15). The screening also revealed three cytokines (IL18, IL17b, and CCL11) that were counter-selected and likely to exert a detrimental effect. The pooled overexpression of the five most enriched cytokines using AAV9 vectors decreased inflammation and reduced cardiac dilatation, persisting at 1\u00a0month after treatment. Individual overexpression of IL9, the top ranking in our functional selection, markedly reduced cardiac inflammation and injury, concomitant with an increase of anti-inflammatory Th2-cells and a reduction of pro-inflammatory Th17- and Th22-cells at 14\u00a0days post-infection. AAV9-mediated FunSel cardiac screening identified IL9 and other four cytokines (IL3, IL4, IL13, and IL15) as cardioprotective factors in CVB3-induced VM in mice.<\/jats:p>","DOI":"10.1038\/s41598-022-11131-w","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T18:05:10Z","timestamp":1651687510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["AAV9-mediated functional screening for cardioprotective cytokines in Coxsackievirus-B3-induced myocarditis"],"prefix":"10.1038","volume":"12","author":[{"given":"Paolo","family":"Carai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ruozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Paye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Debing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bortolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Zentilin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A. V.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Heymans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"11131_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","volume":"12","author":"A Pollack","year":"2015","unstructured":"Pollack, A., Kontorovich, A. R., Fuster, V. & Dec, G. W. Viral myocarditis\u2014Diagnosis, treatment options and current controversies. Nat. Rev. Cardiol. 12, 670\u2013680 (2015).","journal-title":"Nat. Rev. Cardiol."},{"key":"11131_CR2","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. 37, 2129\u20132200m (2016).","journal-title":"Eur. Heart J."},{"key":"11131_CR3","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1161\/CIRCRESAHA.118.313578","volume":"124","author":"C Tsch\u00f6pe","year":"2019","unstructured":"Tsch\u00f6pe, C., Cooper, L. T., Torre-Amione, G. & van Linthout, S. Management of myocarditis-related cardiomyopathy in adults. Circ. Res. 124, 1568\u20131583 (2019).","journal-title":"Circ. Res."},{"key":"11131_CR4","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","volume":"142","author":"PP Liu","year":"2020","unstructured":"Liu, P. P., Blet, A., Smyth, D. & Li, H. The Science underlying COVID-19: Implications for the cardiovascular system. Circulation 142, 68\u201378 (2020).","journal-title":"Circulation"},{"key":"11131_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","volume":"17","author":"L Adamo","year":"2020","unstructured":"Adamo, L., Rocha-Resende, C., Prabhu, S. D. & Mann, D. L. Reappraising the role of inflammation in heart failure. Nat. Rev. Cardiol. 17, 269\u2013285 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"11131_CR6","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41392-020-00360-y","volume":"5","author":"W Hang","year":"2020","unstructured":"Hang, W., Chen, C., Seubert, J. M. & Wang, D. W. Fulminant myocarditis: A comprehensive review from etiology to treatments and outcomes. Signal Transduct. Target. Ther. 5, 287 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"11131_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","volume":"19","author":"G Altan-Bonnet","year":"2019","unstructured":"Altan-Bonnet, G. & Mukherjee, R. Cytokine-mediated communication: A quantitative appraisal of immune complexity. Nat. Rev. Immunol. 19, 205\u2013217 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"11131_CR8","doi-asserted-by":"publisher","first-page":"7388","DOI":"10.1038\/ncomms8388","volume":"6","author":"G Ruozi","year":"2015","unstructured":"Ruozi, G. et al. AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia. Nat. Commun. 6, 7388 (2015).","journal-title":"Nat. Commun."},{"key":"11131_CR9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli, C., Soltys, S., Rengo, G. & Rabinowitz, J. E. Analysis of AAV serotypes 1\u20139 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16, 1073\u20131080 (2008).","journal-title":"Mol. Ther."},{"key":"11131_CR10","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1016\/j.transproceed.2010.05.152","volume":"42","author":"M Zweifel","year":"2010","unstructured":"Zweifel, M., Matozan, K., Dahinden, C., Schaffner, T. & Mohacsi, P. Eotaxin\/CCL11 levels correlate with myocardial fibrosis and mast cell density in native and transplanted rat hearts. Transpl. Proc. 42, 2763\u20132766 (2010).","journal-title":"Transpl. Proc."},{"key":"11131_CR11","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","volume":"124","author":"D Westermann","year":"2011","unstructured":"Westermann, D. et al. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation 124, 2082\u20132093 (2011).","journal-title":"Circulation"},{"key":"11131_CR12","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1002\/eji.201646557","volume":"46","author":"NL Diny","year":"2016","unstructured":"Diny, N. L. et al. Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart. Eur. J. Immunol. 46, 2749\u20132760 (2016).","journal-title":"Eur. J. Immunol."},{"key":"11131_CR13","doi-asserted-by":"crossref","unstructured":"Myers, J. M. et al. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. JCI Insight 1 (2016).","DOI":"10.1172\/jci.insight.85851"},{"key":"11131_CR14","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/CIRCRESAHA.120.316619","volume":"127","author":"J Hoffmann","year":"2020","unstructured":"Hoffmann, J. et al. Circulating Th17 and Th22 cells are associated with CMR imaging biosignatures of diffuse myocardial interstitial remodeling in chronic coronary artery disease. Circ. Res. 127, 699\u2013701. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316619 (2020).","journal-title":"Circ. Res."},{"key":"11131_CR15","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1161\/CIRCULATIONAHA.117.029003","volume":"136","author":"F Bortolotti","year":"2017","unstructured":"Bortolotti, F. et al. In vivo functional selection identifies cardiotrophin-1 as a cardiac engraftment factor for mesenchymal stromal cells. Circulation 136, 1509\u20131524 (2017).","journal-title":"Circulation"},{"key":"11131_CR16","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.4373","volume":"23","author":"S Rauber","year":"2017","unstructured":"Rauber, S. et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat. Med. 23, 938 (2017).","journal-title":"Nat. Med."},{"key":"11131_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/nature05010","author":"L-F Lu","year":"2006","unstructured":"Lu, L.-F. et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature https:\/\/doi.org\/10.1038\/nature05010 (2006).","journal-title":"Nature"},{"key":"11131_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fimmu.2016.00409","volume":"7","author":"M Yu","year":"2016","unstructured":"Yu, M. et al. IL-9 inhibits viral replication in coxsackievirus B3-induced myocarditis. Front. Immunol. 7, 409 (2016).","journal-title":"Front. Immunol."},{"key":"11131_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/129486","volume":"2012","author":"ED Abston","year":"2012","unstructured":"Abston, E. D. et al. Th2 regulation of viral myocarditis in mice: Different roles for TLR3 versus TRIF in progression to chronic disease. Clin. Dev. Immunol. 2012, 1\u201312 (2012).","journal-title":"Clin. Dev. Immunol."},{"key":"11131_CR20","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1128\/jvi.68.8.5126-5132.1994","volume":"68","author":"SA Huber","year":"1994","unstructured":"Huber, S. A. & Pfaeffle, B. Differential Th1 and Th2 cell responses in male and female BALB\/c mice infected with coxsackievirus group B type 3. J. Virol. 68, 5126\u20135132 (1994).","journal-title":"J. Virol."},{"key":"11131_CR21","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.bbi.2008.12.002","volume":"23","author":"S Frisancho-Kiss","year":"2009","unstructured":"Frisancho-Kiss, S. et al. Gonadectomy of male BALB\/c mice increases Tim-3+ alternatively activated M2 macrophages, Tim-3+ T cells, Th2 cells and Treg in the heart during acute coxsackievirus-induced myocarditis. Brain Behav. Immun. 23, 649\u2013657 (2009).","journal-title":"Brain Behav. Immun."},{"key":"11131_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12985-016-0626-z","volume":"13","author":"H Jin","year":"2016","unstructured":"Jin, H. & Guo, X. Valproic acid ameliorates coxsackievirus-B3-induced viral myocarditis by modulating Th17\/Treg imbalance. Virol. J. 13, 168 (2016).","journal-title":"Virol. J."},{"key":"11131_CR23","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.cjca.2020.01.011","volume":"36","author":"Y Yang","year":"2020","unstructured":"Yang, Y., Xu, C., Tang, S. & Xia, Z. Interleukin-9 aggravates isoproterenol-induced heart failure by activating signal transducer and activator of transcription 3 signalling. Can. J. Cardiol. 36, 1770\u20131781 (2020).","journal-title":"Can. J. Cardiol."},{"key":"11131_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/imm.13111","volume":"158","author":"T Zhan","year":"2019","unstructured":"Zhan, T. et al. Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice. Immunology 158, 296\u2013303 (2019).","journal-title":"Immunology"},{"key":"11131_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1165\/rcmb.2017-0287OC","volume":"60","author":"N Sugimoto","year":"2019","unstructured":"Sugimoto, N. et al. IL-9 blockade suppresses silica-induced lung inflammation and fibrosis in mice. Am. J. Respir. Cell Mol. Biol. 60, 232\u2013243 (2019).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"11131_CR26","first-page":"1","volume":"20","author":"Y-B Zhao","year":"2020","unstructured":"Zhao, Y.-B. et al. Interaction between regulatory T cells and mast cells via IL-9 and TGF-beta; production. Oncol. Lett. 20, 1\u20131 (2020).","journal-title":"Oncol. Lett."},{"key":"11131_CR27","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1165\/rcmb.2006-0397OC","volume":"37","author":"S van den Br\u00fble","year":"2007","unstructured":"van den Br\u00fble, S. et al. Profibrotic effect of IL-9 overexpression in a model of airway remodeling. Am. J. Respir. Cell Mol. Biol. 37, 202\u2013209 (2007).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"11131_CR28","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.4049\/jimmunol.1002691","volume":"186","author":"RK Srivastava","year":"2011","unstructured":"Srivastava, R. K. et al. IL-3 attenuates collagen-induced arthritis by modulating the development of Foxp3 + regulatory T cells. J. Immunol. 186, 2262\u20132272 (2011).","journal-title":"J. Immunol."},{"key":"11131_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.4049\/jimmunol.1801629","volume":"204","author":"A Kumar","year":"2020","unstructured":"Kumar, A. et al. IL-3 receptor expression on activated human Th cells is regulated by IL-4, and IL-3 synergizes with IL-4 to enhance Th2 cell differentiation. J. Immunol. 204, 819\u2013831 (2020).","journal-title":"J. Immunol."},{"key":"11131_CR30","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/jgm.1215","volume":"10","author":"ZJ Jiang","year":"2008","unstructured":"Jiang, Z. J. et al. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer. J. Gene Med. 10, 918\u2013929 (2008).","journal-title":"J. Gene Med."},{"key":"11131_CR31","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.molimm.2016.11.006","volume":"81","author":"F Wan","year":"2017","unstructured":"Wan, F. et al. V\u03b31+\u03b3\u03b4T, early cardiac infiltrated innate population dominantly producing IL-4, protect mice against CVB3 myocarditis by modulating IFN\u03b3+ T response. Mol. Immunol. 81, 16\u201325 (2017).","journal-title":"Mol. Immunol."},{"key":"11131_CR32","first-page":"15","volume":"76","author":"L Liu","year":"2014","unstructured":"Liu, L., Yue, Y. & Xiong, S. NK-derived IFN-\u03b3\/IL-4 triggers the sexually disparate polarization of macrophages in CVB3-induced myocarditis. Curr. Ther. Res. Clin. Exp. 76, 15\u201325 (2014).","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"11131_CR33","doi-asserted-by":"publisher","first-page":"99495","DOI":"10.18632\/oncotarget.20111","volume":"8","author":"H Yang","year":"2017","unstructured":"Yang, H., Chen, Y. & Gao, C. Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization. Oncotarget 8, 99495\u201399503 (2017).","journal-title":"Oncotarget"},{"key":"11131_CR34","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.2353\/ajpath.2008.070207","volume":"172","author":"D Cihakova","year":"2008","unstructured":"Cihakova, D. et al. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 172, 1195\u20131208 (2008).","journal-title":"Am. J. Pathol."},{"key":"11131_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/FJC.0000000000000061","volume":"63","author":"Y Yeghiazarians","year":"2014","unstructured":"Yeghiazarians, Y. et al. IL-15: A novel prosurvival signaling pathway in cardiomyocytes. J. Cardiovasc. Pharmacol. 63, 406\u2013411 (2014).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"11131_CR36","doi-asserted-by":"publisher","first-page":"e248","DOI":"10.1016\/S0828-282X(09)70511-2","volume":"25","author":"B Bigalke","year":"2009","unstructured":"Bigalke, B., Schwimmbeck, P. L., Haas, C. S. & Lindemann, S. Effect of interleukin-15 on the course of myocarditis in Coxsackievirus B3-infected BALB\/c mice. Can. J. Cardiol. 25, e248\u2013e254 (2009).","journal-title":"Can. J. Cardiol."},{"key":"11131_CR37","doi-asserted-by":"publisher","first-page":"19167","DOI":"10.1074\/jbc.M910228199","volume":"275","author":"Y Shi","year":"2000","unstructured":"Shi, Y. et al. A novel cytokine receptor-ligand pair: Identification, molecular characterization, and in vivo immunomodutory activity. J. Biol. Chem. 275, 19167\u201319176 (2000).","journal-title":"J. Biol. Chem."},{"key":"11131_CR38","doi-asserted-by":"publisher","first-page":"H76","DOI":"10.1152\/ajpheart.01285.2008","volume":"297","author":"Q Yu","year":"2009","unstructured":"Yu, Q. et al. IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am. J. Physiol. Heart Circ. Physiol. 297, H76\u2013H85 (2009).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"11131_CR39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1006\/jmcc.2000.1242","volume":"32","author":"T Kanda","year":"2000","unstructured":"Kanda, T. et al. Effect of interleukin-18 on viral myocarditis: Enhancement of interferon-\u03b3 and natural killer cell activity. J. Mol. Cell. Cardiol. 32, 2163\u20132171 (2000).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"11131_CR40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.micinf.2014.03.007","volume":"16","author":"L Esper","year":"2014","unstructured":"Esper, L. et al. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection. Microbes Infect. 16, 481\u2013490 (2014).","journal-title":"Microbes Infect."},{"key":"11131_CR41","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.autrev.2019.01.005","volume":"18","author":"A Dagan","year":"2019","unstructured":"Dagan, A., Langevitz, P., Shoenfeld, Y. & Shovman, O. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; A preliminary experience in seven patients. Autoimmun. Rev. 18, 627\u2013631 (2019).","journal-title":"Autoimmun. Rev."},{"key":"11131_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fimmu.2017.00131","volume":"8","author":"G Cavalli","year":"2017","unstructured":"Cavalli, G. et al. Interleukin-1 receptor blockade rescues myocarditis-associated end-stage heart failure. Front. Immunol. 8, 131 (2017).","journal-title":"Front. Immunol."},{"key":"11131_CR43","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2\u2014Preliminary report. N. Engl. J. Med. 383, 1920\u20131931 (2020).","journal-title":"N. Engl. J. Med."},{"key":"11131_CR44","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"11131_CR45","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul, F., Erdfelder, E., Buchner, A. & Lang, A.-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav. Res. Methods 41, 1149\u20131160 (2009).","journal-title":"Behav. Res. Methods"},{"key":"11131_CR46","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00018-016-2423-7","volume":"74","author":"M Rienks","year":"2017","unstructured":"Rienks, M. et al. A novel 72-kDa leukocyte-derived osteoglycin enhances the activation of toll-like receptor 4 and exacerbates cardiac inflammation during viral myocarditis. Cell. Mol. Life Sci. 74, 1511\u20131525 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"11131_CR47","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"11131_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.matbio.2017.09.002","volume":"66","author":"S Deckx","year":"2017","unstructured":"Deckx, S. et al. Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation. Matrix Biol. 66, 110\u2013124 (2017).","journal-title":"Matrix Biol."},{"key":"11131_CR49","doi-asserted-by":"publisher","first-page":"15701","DOI":"10.1038\/s41598-020-72924-5","volume":"10","author":"I Cuijpers","year":"2020","unstructured":"Cuijpers, I. et al. The effect of different anaesthetics on echocardiographic evaluation of diastolic dysfunction in a heart failure with preserved ejection fraction model. Sci. Rep. 10, 15701 (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11131-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11131-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:44:38Z","timestamp":1669344278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11131-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11131"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11131-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"1 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.G. is a founder, consultant, and equity holder in Purespring Therapeutics (London, UK), which owns the rights on the FunSel technology and AAV library. F.B. is a consultant in the same company. All remaining authors, P.C., G.R., A.P., Y.D., J.L., L.Z., E.A.V.J., and S.H., declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7304"}}